Clark Eliana 4
4 · Intellia Therapeutics, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2025-07-01$9.82/sh−1,022$10,036→ 95,369 total
Footnotes (1)
- [F1]Sale of 1,022 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025.